Investor insights
Sectors invested in
Life Science2
Biotechnology2
Health Care2
Funding rounds participated in
$115M sweet spot round size
Most of their 4 investments are in rounds between $10M and $220M
Investor type
Family Investment Office
Basic info
Industry
accounting
Sectors
Private Equity
Growth
Direct Investments
Date founded
1992
Investments made
B
Biosplice Therapeutics raised $438M on August 6, 2018
Investors: Swicorp, Vickers Venture Partners and Starling International Management Limited
U
Undisclosed raised $10M on November 1, 2015
Investors: Everbright Financial Holding H&Q Asia Pacific and Starling International Management Limited
U
Undisclosed raised $10M on November 1, 2013
Investors: GSR Ventures, 合力投资Empower Investment and Starling International Management Limited
B
Biosplice Therapeutics raised $220M on September 1, 2013
Investors: Polar Light Ventures, Vickers Venture Partners and Starling International Management Limited